Topspin is the successor fund to the Long Island Venture Fund, a successful venture capital fund which began investing in 1995.
Business Model:
Revenue: $25M
Employees: 51-200
Address: 1 Station Plz
City: Mamaroneck
State: NY
Zip: 10543
Country: US
Topspin is the successor fund to the Long Island Venture Fund, a successful venture capital fund which began investing in 1995. The firm is an affiliate of Renaissance Technologies, a well-known hedge fund. Тhey look to generate superior returns by partnering with management to build great companies.
Contact Phone:
+19148347370
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
5/2007 | Pionetics | Series C | 3M |
10/2017 | Codagenix | Venture Round | 3M |
5/2003 | Pionetics | Series B | 3.5M |
6/2004 | ArgiNOx Phamaceuticals | Series B | 8M |
7/2017 | Constellation Pharmaceuticals | Series E | 48.5M |
10/2017 | Bear Down Brands | Venture Round | - |
8/2021 | SportPet | Private Equity Round | - |
2/2011 | Celmatix | Series A | 550k |
8/2021 | Coop Home Goods | Private Equity Round | - |
6/2015 | Codagenix | Series A | 2M |
2/2017 | PMV Pharmaceuticals | Series B | 74M |
7/2015 | ThermoLift | Unattributed | 2.8M |
5/2006 | Passport Systems | Series B | 0 |
3/2005 | ArgiNOx Phamaceuticals | Series C | 25M |
8/2003 | comScore | Series E | 12M |
10/2003 | Game Trust | Series A | 1.5M |
8/2013 | SetPoint Medical | Series C | 0 |
5/2020 | reCommerce | Venture Round | - |
11/2005 | Game Trust | Series B | 9M |
10/2003 | netomat | Series B | 0 |
11/2007 | Passport Systems | Series C | 0 |
12/2015 | ORIC Pharmaceuticals | Series B | 53M |
11/2004 | Roche NimbleGen | Series F | 12.8M |
7/2015 | SynchroPET | Seed Round | 725k |
7/2003 | Sensicore | Series B | 6.5M |
10/2013 | Immune Design | Series C | 49M |
3/2012 | Celmatix | Series A | 1.8M |
1/2022 | Mission Product Holdings | Private Equity Round | - |
1/2016 | Alector | Series D | 29.5M |
12/2017 | Rapt Therapeutics | Series C | 60M |
2/2019 | Peloton Therapeutics | Series E | 0 |
8/2005 | Sensicore | Series C | 12M |
12/2015 | Constellation Pharmaceuticals | Series E | 55M |
3/2012 | Aragon Pharmaceuticals, Inc. | Series C | 42M |
9/2019 | SetPoint Medical | Venture Round | 0 |
3/2015 | NGM Biopharmaceuticals | Series D | 57.5M |
6/2007 | Neopolitan Networks | Series A | 3.2M |
6/2002 | comScore | Series D | 20M |
1/2020 | Codagenix | Series B | 0 |
6/2019 | Rapt Therapeutics | Series C | 0 |
8/2019 | ORIC Pharmaceuticals | Series D | 0 |
4/2019 | Celmatix | Venture Round | 0 |
7/2001 | TeraLogic | Venture Round | 17.5M |
7/2013 | NGM Biopharmaceuticals | Series C | 50M |
12/2014 | Codagenix | Unattributed | 100k |
4/2016 | Rapt Therapeutics | Series B | 0 |
4/2018 | Constellation Pharmaceuticals | Series F | 0 |
11/2019 | PMV Pharmaceuticals | Series C | 0 |
9/2015 | Alector | Series C | 32M |
8/2017 | SetPoint Medical | Series D | 0 |
8/2017 | Hubble | Pre Seed Round | - |
1/2022 | Mission Product Holdings | Private Equity Round | - |
8/2021 | Coop Home Goods | Private Equity Round | - |
8/2021 | SportPet | Private Equity Round | - |
5/2020 | reCommerce | Venture Round | - |
1/2020 | Codagenix | Series B | 0 |
11/2019 | PMV Pharmaceuticals | Series C | 0 |
9/2019 | SetPoint Medical | Venture Round | 0 |
8/2019 | ORIC Pharmaceuticals | Series D | 0 |
6/2019 | Rapt Therapeutics | Series C | 0 |
4/2019 | Celmatix | Venture Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|